In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transgene SA

Division of Institut Merieux
www.transgene.fr

Latest From Transgene SA

Deal Watch: Gilead Moves Into Kidney Disease Via Goldfinch Collaboration

Goldfinch’s Kidney Genome Atlas may yield novel therapies for diabetic kidney disease and orphan renal indications, with Gilead holding option rights. Spectrum licenses IP from ImmunGene that could safely harness the potential of interferon therapy in cancer.

Deals Business Strategies

AZ Targets Viral Oncolytics With Transgene Development Deal

AstraZeneca inks a deal with French firm Transgene to co-develop five armed oncolytic vaccinia virus candidates in an area that is hotting up for big pharma.

Research & Development Deals

Monumental Year Ahead For Korean Pharmas As New US Approvals Eyed

2019 could be a monumental year for the South Korean pharma industry, as several new drug assets await the green light from the US FDA.
South Korea Outlook 2019

NEC Moves Beyond IT Tools As It Pursues AI-Driven Drug Discovery Initiative

In an exclusive interview, Japanese tech giant NEC tells Scrip it is aiming for much more than the provision of IT tools in its AI-assisted Drug Discovery Initiative, hoping also to progress assets deriving from cutting-edge technology research. 

Artificial Intelligence Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Hepatic (Liver)
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Institut Merieux
  • Senior Management
  • Philippe Archinard, PhD, Chmn. & CEO
    Jean-Philippe Del, VP, Fin.
    Thibaut du Fayet, PhD, VP, Alliance Mngmt., Project Mngmt. & Mktg.
    Maud Brandely, MD, PhD, CMO
  • Contact Info
  • Transgene SA
    Phone: (33) 3 88 27 91 00
    400 Boulevard Gonthier d'Anderach
    Illkirch Graffenstaden, F-67405
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register